サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1320226

細胞ヘルススクリーニング市場：検査タイプ別、サンプルタイプ別、採取タイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Cellular Health Screening Market with COVID-19 Impact Analysis, By Test Type, By Sample Type, By Collection Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 306 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞ヘルススクリーニング市場：検査タイプ別、サンプルタイプ別、採取タイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 306 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

細胞ヘルススクリーニング市場規模は2022年に30億690万米ドルと評価され、2023年から2030年にかけてCAGR 10.3%で拡大

細胞ヘルススクリーニング市場-市場力学：

予防ヘルスケアに対する政府の関心の高まりと慢性疾患の負担増が、細胞ヘルススクリーニング市場の成長を促進する要因であると予測されます。

世界各国の政府は、医療システムにおける疾病の負担を軽減する戦略的アプローチとして、予防ヘルスケアをますます重視するようになっています。細胞ヘルススクリーニングは、潜在的な健康問題を早期に発見し、より効果的で安価な治療を可能にします。心臓病、糖尿病、がんなどの慢性疾患は世界的に増加傾向にあります。世界保健機関（WHO）によると、心血管疾患（CVDs）は世界の死因の第一位で、毎年推定1,790万人の命を奪っています。これらの疾患は長い時間をかけて発症することが多く、生活習慣の要因と関連しています。ゲノミクス、バイオインフォマティクス、mヘルスにおける技術の進歩は、細胞ヘルススクリーニングの新たな機会を開いています。しかし、遺伝子検査と健康スクリーニングに関する厳しい規制は、市場の成長を妨げる可能性があります。

細胞ヘルススクリーニング市場-主要洞察：

  • 当社のリサーチアナリストが共有した分析によると、世界の細胞ヘルススクリーニング市場は予測期間（2023-2030年）に約10.3%のCAGRで毎年成長すると予測されています。
  • 細胞ヘルススクリーニング産業は、持続可能な成長に対する意識の高まりにより、著しい速度で成長すると予測される
  • 検査タイプ別では、単一検査パネルが2022年に最大の市場シェアを示すと予測されます。
  • 検体タイプ別では、血液が2022年の主要タイプでした。
  • 採取タイプ別では、ホスピタリティが2022年の主要タイプでした。
  • 地域別では、北米が2022年の売上高をリード

細胞ヘルススクリーニング市場-セグメンテーション分析：

細胞ヘルススクリーニングの世界市場は、検査タイプ、サンプルタイプ、採取タイプ、地域に基づいてセグメント化されます。

市場は検査タイプに基づいて2つのカテゴリーに分けられる：単一検査パネルと複数検査パネルです。単一検査パネルが市場を独占しています。細胞ヘルススクリーニングと単一検査パネルは貴重な予防ヘルスケアツールです。潜在的な健康問題が重大な問題に発展する前に発見するのに役立ちます。

市場は検体の種類によって4つのカテゴリーに分けられる：血液、唾液、血清、尿です。血液サンプルが市場を独占しています。血液サンプルを利用した細胞健康診断は、人の健康について多くのことを明らかにすることができます。炎症、酸化ストレス、免疫機能、細胞レベルでのその他の健康指標など、多くのパラメータに関する情報を提供することができます。

市場は、採取タイプに基づいて4つのカテゴリーに分けられる：家庭、オフィス、病院、診断ラボです。ホスピタリティ部門が市場を独占しており、予測期間中もその優位性を維持するとみられます。ホスピタリティ・スクリーニングは、病院における予防ヘルスケア、診断、個別投薬の重要な一部です。

細胞ヘルススクリーニング市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、個人の健康に対する意識の高まりと医療費の増加により、細胞ヘルススクリーニング市場の成長を支配すると予想されます。この地域では、多額のヘルスケア支出が行われています。特に米国は、国民1人当たりのヘルスケア支出が世界のどの国よりも多いです。National Health Expenditure Dataによると、2021年の国民医療費は2.7%増の4兆3,000億米ドル、1人当たり1万2,914米ドルに達し、国内総生産（GDP）の18.3%を占める。欧州は、予防医療と慢性疾患の予防に政府が資金を提供しているため、細胞スクリーニング市場にとって2番目に大きな市場です。

細胞健診市場-競合情勢：

細胞ヘルススクリーニング分野における競合の増加は、需要の高まりに起因しています。この競合には、診断事業者、ラボ、病院、その他のヘルスケアプロバイダーが含まれます。これらの企業は、利用可能な検査数、精度、コスト、納期、顧客サービスなどのパラメータで競争しています。しかし、競合は課題を生み出します。例えば、企業は、検査の正確性と信頼性を確保するために、科学と技術の最新の進歩に対応し続けなければならないです。また、厳しい品質管理を守りつつ、規制を管理しなければならないです。また、細胞ヘルススクリーニングのための新しい技術や手法の開発によっても、需要が促進されています。これらの検査は、より高度で効率的になるにつれて、ヘルスケアにおいてますます頻繁に使用されるようになっています。例えば、2020年5月12日、ジェノバ・ダイアグノスティックスはFDA緊急使用認可（EUA）に基づきCOVID-19検査を導入しました。この検査は、米国内の病院、大規模医療システム、厳選された医療機関をサポートするものです。ジェノバは現在、ノースカロライナ州アッシュビルの研究所でCOVID-19検査を実施しており、検査能力の増強に取り組んでいます。

最近の動き

2023年2月9日、米国最大級のフルサービス専門検査機関であるBio Reference Laboratories Health LLCは、Roche Diagnostics社のCINtec PLUS細胞診検査を提供する最初の商業検査機関のひとつとなることを発表しました。CINtec PLUS Cytologyは、高リスクのヒトパピローマウイルス（HPV）検査結果を有する患者に対する唯一のFDA承認二重染色トリアージ検査です。

研究の主な特徴

  • この調査レポートは、細胞ヘルススクリーニング市場の市場規模、年間平均成長率（CAGR %）、2022年を基準年とした推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、細胞ヘルススクリーニング市場に関する最新動向とトレンドを顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、細胞ヘルススクリーニング市場の魅力的な投資提案マトリクスを説明します。
  • レポート全体では、新規投資機会、既存企業が直面する課題、細胞ヘルススクリーニング市場で持続するための成長要因を特定している
  • COVID-19が細胞ヘルススクリーニング市場規模、予測、CAGR、市場力学に与える影響については、調査対象範囲で詳細に論じています。COVID後の細胞健診市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに細胞ヘルススクリーニング市場の包括的な見解を提供するために、細胞ヘルススクリーニング市場の競合情勢と主要イノベーター分析も含めています。
  • 本レポートでは、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする、成長展望マッピング分析を網羅しています。
  • 主要市場参入企業の詳細な企業プロファイルを掲載しており、セルラーヘルス検診市場で事業展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。
  • さらに、本レポートは、世界レベルおよび地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • この調査レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 細胞ヘルススクリーニング市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 細胞ヘルススクリーニングの主要な市場動向

  • 細胞ヘルススクリーニング市場促進要因
  • 細胞ヘルススクリーニング市場抑制要因
  • 細胞ヘルススクリーニング市場の機会
  • 細胞ヘルススクリーニングの今後の動向

第4章 細胞ヘルススクリーニング業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 細胞ヘルススクリーニング市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 細胞ヘルススクリーニング市場情勢

  • 細胞ヘルススクリーニング市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 細胞ヘルススクリーニング市場- 検査タイプ別

  • 概要
    • 検査タイプ別のセグメントシェア分析
    • 単一のテストパネル
      • テロメア検査
      • 酸化ストレス試験
      • 炎症検査
      • 重金属検査
    • マルチテストパネル

第8章 細胞ヘルススクリーニング市場- サンプルタイプ別

  • 概要
    • サンプルタイプ別のセグメントシェア分析
    • 血液
    • 唾液
    • 血清
    • 尿

第9章 細胞ヘルススクリーニング市場- 採取タイプ別

  • 概要
    • 採取タイプ別のセグメントシェア分析
    • 家庭
    • オフィス
    • 病院
    • 診断研究所

第10章 細胞ヘルススクリーニング市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 細胞ヘルススクリーニング北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 細胞ヘルススクリーニング欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 細胞ヘルススクリーニングアジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 細胞ヘルススクリーニングラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 細胞ヘルススクリーニング中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 細胞ヘルススクリーニング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Life Length
    • SpectraCell Laboratories, Inc.
    • RepeatDx
    • Cell Science Systems
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • OPKO Health, Inc.
    • Genova Diagnostics（GDX）
    • Immundiagnostik AG
    • DNA Labs India

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cellular Health Screening Market: Test Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Cellular Health Screening Market, by Test Type 2018-2030 (USD Million)
  • TABLE Cellular Health Screening Market: Sample Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Sample Type
  • TABLE Global Cellular Health Screening Market, by Sample Type 2018-2030 (USD Million)
  • TABLE Cellular Health Screening Market: Collection Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Collection Type
  • TABLE Global Cellular Health Screening Market, by Collection Type 2018-2030 (USD Million)
  • TABLE Cellular Health Screening Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cellular Health Screening Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cellular Health Screening Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cellular Health Screening Market, by Test Type, 2018-2030 (USD Million)
  • TABLE North America Cellular Health Screening Market, by Sample Type, 2018-2030 (USD Million)
  • TABLE North America Cellular Health Screening Market, by Collection Type, 2018-2030 (USD Million)
  • TABLE Europe Cellular Health Screening Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cellular Health Screening Market, by Test Type, 2018-2030 (USD Million)
  • TABLE Europe Cellular Health Screening Market, by Sample Type, 2018-2030 (USD Million)
  • TABLE Europe Cellular Health Screening Market, by Collection Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cellular Health Screening Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cellular Health Screening Market, by Test Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cellular Health Screening Market, by Sample Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cellular Health Screening Market, by Collection Type, 2018-2030 (USD Million)
  • TABLE Latin America Cellular Health Screening Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cellular Health Screening Market, by Test Type, 2018-2030 (USD Million)
  • TABLE Latin America Cellular Health Screening Market, by Sample Type, 2018-2030 (USD Million)
  • TABLE Latin America Cellular Health Screening Market, by Collection Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cellular Health Screening Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cellular Health Screening Market, by Test Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cellular Health Screening Market, by Sample Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cellular Health Screening Market, by Collection Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cellular Health Screening Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Test Type segment market share analysis, 2022 & 2030
  • FIGURE Test Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sample Type segment market share analysis, 2022 & 2030
  • FIGURE Sample Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Collection Type segment market share analysis, 2022 & 2030
  • FIGURE Collection Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cellular Health Screening Market share and leading players, 2022
  • FIGURE Europe Cellular Health Screening Market share and leading players, 2022
  • FIGURE Asia Pacific Cellular Health Screening Market share and leading players, 2022
  • FIGURE Latin America Cellular Health Screening Market share and leading players, 2022
  • FIGURE Middle East and Africa Cellular Health Screening Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cellular Health Screening Market share analysis by country, 2022
  • FIGURE Germany Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cellular Health Screening Market share analysis by country, 2022
  • FIGURE India Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cellular Health Screening Market share analysis by country, 2022
  • FIGURE Brazil Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cellular Health Screening Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cellular Health Screening Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1537

REPORT HIGHLIGHT

The Cellular Health Screening Market size was valued at USD 3,006.9 million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.

Cellular health screening is a relatively new area of scientific research that explores how cells respond to environmental stimuli, dietary habits, and lifestyle choices. A wide range of screening tests are available. Some tests are considered to have a benefit, whereas the benefit of other tests is not so clear. The use of advanced testing equipment, known as the Bio Impedance Analysis device, makes it possible to assess how your body ages based on factors like lifestyle, environment, emotions and diet. They use this equipment to conduct Bio Impedance tests, VLA tests, and Cellular Health Analysis, among others. These tests are designed to monitor the overall health of patients. The accuracy of this device and the readings is what makes this health-screening test popular among Naturopaths.

Cellular Health Screening Market- Market Dynamics:

Rising government focus on preventive healthcare and the increasing burden of chronic diseases are the factors that are expected to drive the growth of the Cellular Health Screening Market.

Governments around the world are increasingly emphasizing preventative healthcare as a strategic approach to reducing the burden of diseases on their health systems. Cellular health screening detects potential health issues early, enabling more effective and affordable therapies. Chronic diseases such as heart disease, diabetes, and cancer are on the rise worldwide. According to World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. These disorders frequently develop over time and are linked to lifestyle factors that can be discovered and corrected using cellular health screening. Technological advancements in genomics, bioinformatics, and mHealth are opening up new opportunities for cellular health screening. However, stringent regulations around genetic testing and health screening can hinder the growth of the market.

Cellular Health Screening Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cellular Health Screening market is estimated to grow annually at a CAGR of around 10.3% over the forecast period (2023-2030)
  • The Cellular Health Screening industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Test Type segmentation, Single Test Panels were predicted to show maximum market share in the year 2022
  • Based on Sample Type segmentation, blood was the leading type in 2022
  • Based on Collection Type segmentation, the Hospital sector was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Cellular Health Screening Market- Segmentation Analysis:

The Global Cellular Health Screening Market is segmented on the basis of Test Type, Sample Type, Collection Type, and Region.

The market is divided into two categories based on Test Type: Single Test Panels and Multi-Test Panels. The Single Test Panels dominate the market. Cellular health screening and single test panels are valuable preventative healthcare tools. They aid in the detection of potential health issues before they become significant difficulties.

The market is divided into four categories based on Sample Type: Blood, Saliva, Serum, and Urine. Blood sample dominates the market. A cellular health screening utilizing a blood sample can reveal a lot about a person's health. It can provide information on many parameters such as inflammation, oxidative stress, immunological function, and other health indicators at the cellular level.

The market is divided into four categories based on Collection Type: Home, Office, Hospital, and Diagnostic Labs. The Hospital sector dominates the market and is likely to maintain its dominance during the forecast period. Cellular health screenings are an important part of preventive healthcare, diagnostics, and individualized medication in the hospital setting.

Cellular Health Screening Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Cellular Health Screening Market, due to increasing awareness regarding health among individuals, and growing healthcare expenditure. there's a growing consciousness about health and wellness among North American populations. In this region, a significant amount of healthcare spending. The United States, in particular, spends more on healthcare per capita than any other country in the world. National Health Expenditure grew 2.7% to USD 4.3 trillion in 2021, or USD12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP), according to National Health Expenditure Data. Europe is the second largest market for Cellular Health Screening Market, due to government funding for preventative healthcare and the rising prevention of chronic diseases.

Cellular Health Screening Market- Competitive Landscape:

Increased competition in the field of cellular health screenings has resulted from rising demand. Diagnostic businesses, labs, hospitals, and other healthcare providers are included in this competition. They compete on parameters such as the number of tests available, accuracy, cost, turnaround time, and customer service. However, competition creates challenges. Companies, for example, must keep up with the newest advances in science and technology to ensure their tests are accurate and dependable. They must also manage regulatory regulations while adhering to tight quality controls. Demand is also being driven by the development of novel technologies and techniques for cellular health screening. These tests are being used increasingly frequently in healthcare as they grow more advanced and efficient. For example, on 12 May 2020, Genova Diagnostics introduced a COVID-19 test under the FDA Emergency Use Authorization (EUA). This testing will help support hospitals, larger medical systems, and select institutions across the United States. Genova is currently performing its COVID-19 testing at their Asheville, NC laboratory and working to increase the capacity of testing.

Recent Developments:

On Feb. 9, 2023, Bio Reference Laboratories Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec PLUS Cytology test from Roche Diagnostics. CINtec PLUS Cytology is the only FDA-approved dual-stain triage test for patients who have a high-risk human papillomavirus (HPV) result.

Key features of the study:

  • This proposed research study on Cellular Health Screening market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cellular Health Screening market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cellular Health Screening market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cellular Health Screening market
  • Impact of COVID-19 on Cellular Health Screening market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cellular Health Screening market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cellular Health Screening market, we have also included competitive landscape and key innovator analysis for the Cellular Health Screening market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cellular Health Screening market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cellular Health Screening market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELLULAR HEALTH SCREENING MARKET KEY PLAYERS

  • Life Length
  • SpectraCell Laboratories, Inc.
  • RepeatDx
  • Cell Science Systems
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • OPKO Health, Inc.
  • Genova Diagnostics (GDX)
  • Immundiagnostik AG
  • DNA Labs India

GLOBAL CELLULAR HEALTH SCREENING MARKET, BY TEST TYPE

  • Single Test Panels
  • Telomere Tests
  • Oxidative Stress Tests
  • Inflammation Tests
  • Heavy Metals Tests
  • Multi-test Panels

GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE

  • Blood
  • Saliva
  • Serum
  • Urine

GLOBAL CELLULAR HEALTH SCREENING MARKET, BY COLLECTION TYPE

  • Home
  • Office
  • Hospital
  • Diagnostic Labs

GLOBAL CELLULAR HEALTH SCREENING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cellular Health Screening Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cellular Health Screening Market Snippet by Test Type
    • 2.1.2. Cellular Health Screening Market Snippet by Sample Type
    • 2.1.3. Cellular Health Screening Market Snippet by Collection Type
    • 2.1.4. Cellular Health Screening Market Snippet by Country
    • 2.1.5. Cellular Health Screening Market Snippet by Region
  • 2.2. Competitive Insights

3. Cellular Health Screening Key Market Trends

  • 3.1. Cellular Health Screening Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cellular Health Screening Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cellular Health Screening Market Opportunities
  • 3.4. Cellular Health Screening Market Future Trends

4. Cellular Health Screening Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cellular Health Screening Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cellular Health Screening Market Landscape

  • 6.1. Cellular Health Screening Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cellular Health Screening Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2022 & 2030 (%)
    • 7.1.2. Single Test Panels
      • 7.1.2.1. Telomere Tests
      • 7.1.2.2. Oxidative Stress Tests
      • 7.1.2.3. Inflammation Tests
      • 7.1.2.4. Heavy Metals Tests
    • 7.1.3. Multi-test Panels

8. Cellular Health Screening Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2022 & 2030 (%)
    • 8.1.2. Blood
    • 8.1.3. Saliva
    • 8.1.4. Serum
    • 8.1.5. Urine

9. Cellular Health Screening Market - By Collection Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Collection Type, 2022 & 2030 (%)
    • 9.1.2. Home
    • 9.1.3. Office
    • 9.1.4. Hospital
    • 9.1.5. Diagnostic Labs

10. Cellular Health Screening Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cellular Health Screening Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cellular Health Screening Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cellular Health Screening Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cellular Health Screening Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cellular Health Screening Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Collection Type, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cellular Health Screening Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Life Length
    • 11.2.2. SpectraCell Laboratories, Inc.
    • 11.2.3. RepeatDx
    • 11.2.4. Cell Science Systems
    • 11.2.5. Quest Diagnostics Incorporated
    • 11.2.6. Laboratory Corporation of America Holdings
    • 11.2.7. OPKO Health, Inc.
    • 11.2.8. Genova Diagnostics (GDX)
    • 11.2.9. Immundiagnostik AG
    • 11.2.10. DNA Labs India

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us